FDA Adverse Event Injury Summary report: N

ZIMMER M/L TAPER FEMORAL STEM PRESS-FIT

MDR report key: 2542437 · Received April 13, 2012

Report

Report Number
1822565-2012-00824
Event Type
Injury
Date Received
April 13, 2012
Date of Event
February 28, 2012
Report Date
March 17, 2012
Manufacturer
ZIMMER, INC.
Product Code
LZO
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

INFO WAS RECEIVED FROM A HEALTH PROFESSIONAL WHO IS NOT REQUIRED TO COMPLETE FORM 3500A. IT IS REPORTED THAT THE PT FELL AND EXPERIENCED PAIN. X-RAYS AT 6 WEEKS SHOWED STEM SUBSIDENCE THAT WAS NOT SEEN IN IMMEDIATE POST-FALL X-RAYS. THE DEVICES WERE IMPLANTED (B)(6) 2012, SO THE PT'S FALL OCCURRED APPROXIMATELY 1.5 WEEKS POST-OP. SURGICAL NOTES WERE NOT PROVIDED. X-RAYS WERE NOT PROVIDED; IT IS UNKNOWN WHETHER THE COMPONENTS WERE IMPLANTED WITH THE CORRECT FIT AND ORIENTATION AS PER THE SURGICAL TECHNIQUE. IN GENERAL, PT FACTORS THAT MAY AFFECT THE PERFORMANCE OF THE COMPONENTS INCLUDE: AGE, BONE QUALITY, HEIGHT/WEIGHT, ACTIVITY LEVEL, TYPE OF ACTIVITY (LOW IMPACT VS HIGH IMPACT), AND RELEVANT MEDICAL HISTORY. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED WITH THE INFO PROVIDED. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT FIND ANY DEVIATIONS OR ANOMALIES. IT IS NOT SUSPECTED THAT THE PRODUCT FAILED TO MEET SPECIFICATIONS. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY EVIDENCE OF PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFO BE RECEIVED, THE COMPLAINT WILL BE REOPENED. ZIMMER, INC CONSIDERS THE INVESTIGATION CLOSED.

Description of Event or Problem · 1

IT IS REPORTED THAT AFTER EXPERIENCING A FALL, THE PT IS PRESENTING WITH INCREASED PAIN AND STEM SUBSIDENCE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ZIMMER M/L TAPER FEMORAL STEM PRESS-FIT LZO ZIMMER, INC. 61930806

Patients

Seq Age Sex Outcome Treatment
1 48 YR Other